GKB — GKB Ophthalmics Share Price
Last trade - 00:00- IN₹322.35m
- IN₹421.76m
- IN₹1.49bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.61 | ||
| Price to Tang. Book | 0.61 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.22 | ||
| EV to EBITDA | 4.83 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9% | ||
| Return on Equity | 6.19% | ||
| Operating Margin | 3.67% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 709.38 | 754.75 | 882.54 | 1,089.88 | 1,490.63 | n/a | n/a | 21.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Directors
- Krishna Gupta CHM
- Noel da Silva CFO
- Subhash Redkar EDR
- K. Gupta NED (71)
- Vikram Gupta NED (44)
- Prakash Joshi NED (61)
- Joseph D'Costa NID (65)
- Shashi Katreddi NID
- Anil Palekar NID (63)
- Sadashiv Shet NID (62)
- Last Annual
- March 31st, 2026
- Last Interim
- June 30th, 2026
- Incorporated
- December 10th, 1981
- Public Since
- April 22nd, 1996
- No. of Employees
- 156
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 5,040,580
- Address
- Karaswada, BARDEZ, 403526
- Web
- https://www.gkb.net/
- Phone
- +91 8322257253
- Contact
- Pooja Bicholkar
- Auditors
- MSKA & Associates LLP
Similar to GKB
Avience Biomedicals
National Stock Exchange of India
Borosil Scientific
National Stock Exchange of India
Entero Healthcare Solutions
National Stock Exchange of India
Fischer Medical Ventures
National Stock Exchange of India
Galaxy Medicare
National Stock Exchange of India
FAQ
As of Today at 02:52 UTC, shares in GKB Ophthalmics are trading at IN₹63.95. This share price information is delayed by 15 minutes.
Shares in GKB Ophthalmics last closed at IN₹63.95 and the price had moved by over the past 365 days. In terms of relative price strength the GKB Ophthalmics share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreGKB Ophthalmics does not currently pay a dividend.
GKB Ophthalmics does not currently pay a dividend.
GKB Ophthalmics does not currently pay a dividend.
To buy shares in GKB Ophthalmics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹63.95, shares in GKB Ophthalmics had a market capitalisation of IN₹322.35m.
Here are the trading details for GKB Ophthalmics:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: GKB
Based on an overall assessment of its quality, value and momentum GKB Ophthalmics is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like GKB Ophthalmics. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹63.95, shares in GKB Ophthalmics were trading -1.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The GKB Ophthalmics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹63.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
GKB Ophthalmics' management team is headed by:
- Krishna Gupta - CHM
- Noel da Silva - CFO
- Subhash Redkar - EDR
- K. Gupta - NED
- Vikram Gupta - NED
- Prakash Joshi - NED
- Joseph D'Costa - NID
- Shashi Katreddi - NID
- Anil Palekar - NID
- Sadashiv Shet - NID